Image

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

We're studying ADEL-Y01's safety and effects in a clinical trial.

Recruiting
18-80 years
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is exploring a new treatment, ADEL-Y01, for Alzheimer's disease (AD). AD is a brain illness causing memory loss. The study has two parts: Part 1 tests a single dose in healthy adults aged 18-65; Part 2 tests multiple doses in people aged 50-80 with mild memory problems due to AD. ADEL-Y01 is a special type of medicine called a monoclonal antibody, which helps clear bad proteins in the brain. The study checks how safe ADEL-Y01 is, how the body processes it, and its effects on the brain. Participants must be healthy, meet specific health criteria, and agree to the study rules.

  • Commitment: Up to 12 weeks for Part 1; up to 22 weeks for Part 2.
  • Visits: Frequent visits to a research center for check-ups and medicine doses.
  • Risks: Possible side effects being studied, including safety and tolerability.
Print
Study details
    Alzheimer Disease

NCT06247345

Alzheimer's Disease Expert Lab (ADEL), Inc.

6 April 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.